Exhibit
99.1

Allegro
is Awarded $875,000 plus Interest and 519,736 Shares from Escrow
Account
LOS
ANGELES February 4, 2009 – Allegro Biodiesel Corporation (OTC: ABDS) (“Allegro”
or the “Company”) announced that it has received an arbitration award (the
“Award”) relating to its 2006 acquisition (the “Vanguard Acquisition”) of
Vanguard Synfuels, LLC (“Vanguard”) from the former members of Vanguard (the
“Former Members”). The Award consists of (i) approximately $875,000
in cash plus all accrued interest from September 20, 2006, through the time of
payment, expected to be in mid-February, 2009, and (ii) 519,736 shares of
Allegro’s common stock and shall be paid from the escrow account (the “Escrow
Account”) that was established in connection with the Vanguard
Acquisition.
The Award
resulted from binding arbitration proceedings that were agreed to by both
parties under the terms of the Settlement Agreement entered into by the parties
as part of the Company’s sale of Vanguard and its related biodiesel assets to
Consolidated Energy Holdings, LLC in June 2008. The arbitrator found
that the Former Members had breached certain representations and warranties made
in the Contribution Agreement that was entered into by Allegro and the Former
Members in connection with the Vanguard Acquisition. The amount of
the Award constitutes damages for such breaches. All remaining cash
and escrow shares in the Escrow Account (approximately $403,752 plus all accrued
interest from September 20, 2006 through the time of payment, expected to be in
mid-February and 340,053 shares) shall be released to the Former
Members.
The
proceeds from the Award will significantly bolster the Company’s cash position.
Accordingly, Allegro will continue to seek to maximize shareholder value through
actively seeking and evaluating potential strategic
transactions. Allegro is currently in discussions with several
parties regarding possible transactions.
Caution
Regarding Forward-Looking Statements
This
press release includes statements that may constitute forward-looking statements
made pursuant to the safe harbor provisions of the U.S. Private Securities
Litigation Reform Act of 1995. To the extent that this press release discusses
expectations about future financial performance, possible strategic
transactions, future disclosures, or other statements about the future, such
statements are forward-looking and are subject to a number of risk factors and
uncertainties that could cause actual results to differ materially from the
statements made. These factors include the risk factors discussed in the Risk
Factors, Business Description and Management's Discussion and Analysis sections
of our Annual Report on Form 10-KSB for the year ended December 31, 2007, and
subsequent Quarterly Reports on Form 10-QSB and current reports on Form
8-K.
Contact:
Tel: (310)
670-2093
Fax: (310)
670-4107
E-mail: info@allegrobio.com
http://b2i.us/irpass.asp?BzID=1496&to=ea&s=0